“…Intriguingly, αB-crystallin inhibits activation of this key cell death protease that lies at the convergence of both apoptotic pathways, thereby conferring protection against a broad range of apoptotic stimuli, including chemotherapy and other cytotoxic drugs, tumor necrosis factor (TNF)-α, TNF-related apoptosis-inducing ligand (TRAIL), growth factor deprivation, matrix detachment-induced apoptosis, hypoxia, hypertonic and oxidative stress, ultraviolet radiation and others (Kegel et al, 1996; Mehlen et al, 1996; Andley et al, 2000; Kamradt et al, 2001, 2002, 2005; Stegh et al, 2008; Ruan et al, 2011; Dou et al, 2012; Petrovic et al, 2013; van de Schootbrugge et al, 2014; Malin et al, 2015). Conversely, silencing αB-crystallin confers sensitivity to cell death stimuli (Kamradt et al, 2005; Moyano et al, 2006; Lee et al, 2012; Petrovic et al, 2013; Pereira et al, 2014; Malin et al, 2015). Procaspase-3 is activated by a two-step mechanism in which initiator caspases (caspase-9 in the intrinsic pathway or caspases-8 or -10 in the extrinsic pathway) cleave procaspase-3 between its large and small subunits to generate a p24 intermediate, which subsequently undergoes autoproteolytic cleavage to remove its N-terminal domain (Cryns & Yuan, 1998; Logue & Martin, 2008).…”